Literature DB >> 21137016

Identification of distinctive protein expression patterns in colorectal adenoma.

Francis F Lam1, Lucy Jankova, Owen F Dent, Mark P Molloy, Sun Young Kwun, Candice Clarke, Pierre Chapuis, Graham Robertson, Philip Beale, Stephen Clarke, E Les Bokey, Charles Chan.   

Abstract

PURPOSE: As a pre-malignant precursor, adenoma provides an ideal tissue for proteome profiling to investigate early colorectal cancer development and provide possible targets for preventive interventions. The aim of this study was to identify patterns of differential protein expression that distinguish colorectal adenoma from normal tissue. EXPERIMENTAL
DESIGN: Twenty paired samples of adenoma and normal mucosa were analysed by 2-DE and MALDI-TOF/TOF MS to detect proteins with ≥2-fold differential expression.
RESULTS: Four proteins were up-regulated in adenoma (Annexin A3, S100A11, S100P and eIF5A-1) and three were down-regulated (Galectin-1, S100A9 and FABPL). S100P, galectin-1, S100A9 and FABPL expression was localised by immunohistochemistry. CONCLUSIONS AND CLINICAL RELEVANCE: Distinctive patterns of in vivo protein expression in colorectal adenoma were identified for the first time. These proteins have important functions in cell differentiation, proliferation and metabolism, and may play a crucial role in early colorectal carcinogenesis. The ability to recognise premalignant lesions may have important applications in cancer prevention.
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21137016     DOI: 10.1002/prca.200900084

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  18 in total

1.  Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.

Authors:  Anuli Uzozie; Paolo Nanni; Teresa Staiano; Jonas Grossmann; Simon Barkow-Oesterreicher; Jerry W Shay; Amit Tiwari; Federico Buffoli; Endre Laczko; Giancarlo Marra
Journal:  Mol Cell Proteomics       Date:  2014-02-24       Impact factor: 5.911

Review 2.  The translation factor eIF5A and human cancer.

Authors:  Michael B Mathews; John W B Hershey
Journal:  Biochim Biophys Acta       Date:  2015-05-13

3.  High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker.

Authors:  Ming-Bing Xiao; Feng Jiang; Wen-Kai Ni; Bu-You Chen; Cui-Hua Lu; Xiao-Yan Li; Run-Zhou Ni
Journal:  Med Oncol       Date:  2011-09-13       Impact factor: 3.064

Review 4.  eIF5A isoforms and cancer: two brothers for two functions?

Authors:  M Caraglia; M H Park; E C Wolff; M Marra; A Abbruzzese
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

5.  Esophageal cancer alters the expression of nuclear pore complex binding protein Hsc70 and eIF5A-1.

Authors:  Mehdi Moghanibashi; Ferdous Rastgar Jazii; Zahra-Soheila Soheili; Maryam Zare; Aliasghar Karkhane; Kazem Parivar; Parisa Mohamadynejad
Journal:  Funct Integr Genomics       Date:  2013-03-29       Impact factor: 3.410

6.  Assessment of laparoscopic training for gynecological malignancies using Thiel-embalmed human cadavers.

Authors:  Tomoka Usami; Toru Fujioka; Ayaka Yoshida; Hitomi Miyaue; Toshiaki Yasuoka; Yuka Uchikura; Kazuko Takagi; Yuko Matsubara; Takashi Matsumoto; Keiichi Matsubara; Takashi Sugiyama
Journal:  Mol Clin Oncol       Date:  2018-09-07

7.  Proteomic Analysis of Hepatocellular Carcinoma Tissues With Encapsulation Shows Up-regulation of Leucine Aminopeptidase 3 and Phosphoenolpyruvate Carboxykinase 2.

Authors:  Keisuke Kuhara; Takao Kitagawa; Byron Baron; Kazuhiro Tokuda; Kazuhiko Sakamoto; Hiroaki Nagano; Kazuyuki Nakamura; Masanobu Kobayashi; Hiroki Nagayasu; Yasuhiro Kuramitsu
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

8.  Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.

Authors:  Felix H Shek; Sarwat Fatima; Nikki P Lee
Journal:  Int J Hepatol       Date:  2012-09-18

9.  Tissue biomarkers of breast cancer and their association with conventional pathologic features.

Authors:  L Chung; S Shibli; K Moore; E E Elder; F M Boyle; D J Marsh; R C Baxter
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

10.  Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

Authors:  Michael Preukschas; Christian Hagel; Alexander Schulte; Kristoffer Weber; Katrin Lamszus; Henning Sievert; Nora Pällmann; Carsten Bokemeyer; Joachim Hauber; Melanie Braig; Stefan Balabanov
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.